Effects of Fufang Biejia Ruangan Pills on hepatic fibrosis in vivo and in vitro

doi:10.3748/wjg.v19.i32.5326

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 19, Issue 32

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6455)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series, Tables (1-3) series.

Item

Count

PDF

382

HTML

4152

Figures (1-3)

163

Tables (1-3)

127

Sum=4824

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

846

Download

785

Sum=1631

Aug 28, 2013 (publication date) through May 3, 2024

Times Cited of This Article

Times Cited (23)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Aug 28, 2013; 19(32): 5326-5333
Published online Aug 28, 2013. doi: 10.3748/wjg.v19.i32.5326

Full Size Figure Download Figure

Figure 3 Western blotting for Smad3 expression in rats. A: Normal rats; B: Rats with hepatic fibrosis; C: Fufang Biejia Ruangan Pill-treated rats; D: Colchicine-treated rats.

Citation: Yang FR, Fang BW, Lou JS. Effects of Fufang Biejia Ruangan Pills on hepatic fibrosis in vivo and in vitro. World J Gastroenterol 2013; 19(32): 5326-5333
URL: https://www.wjgnet.com/1007-9327/full/v19/i32/5326.htm
DOI: https://dx.doi.org/10.3748/wjg.v19.i32.5326